Compare ELDN & FUBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELDN | FUBO |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.8M | 265.1M |
| IPO Year | 2014 | 2011 |
| Metric | ELDN | FUBO |
|---|---|---|
| Price | $2.98 | $11.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $8.50 | ★ $20.33 |
| AVG Volume (30 Days) | 947.9K | ★ 1.4M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $4,271,000.00 |
| Revenue This Year | N/A | $44.64 |
| Revenue Next Year | N/A | $5.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10317.07 |
| 52 Week Low | $1.35 | $1.02 |
| 52 Week High | $4.60 | $14.54 |
| Indicator | ELDN | FUBO |
|---|---|---|
| Relative Strength Index (RSI) | 31.65 | 60.18 |
| Support Level | $2.68 | $8.49 |
| Resistance Level | $3.21 | $11.68 |
| Average True Range (ATR) | 0.16 | 0.73 |
| MACD | -0.04 | 0.09 |
| Stochastic Oscillator | 10.88 | 55.01 |
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
FuboTV Inc is a sports-first, Pay TV replacement product offering subscribers access to tens of thousands of live sporting events annually, alongside news and entertainment content, both live and on demand. Its platform is designed to empower customers to seamlessly access content through streaming devices and on Smart TVs, mobile phones, tablets, and computers. The company offers subscribers a live TV streaming service with the option to purchase incremental features, including additional content or enhanced functionality suited to their preferences. Its subscription packages (including Fubo Essential, Pro, Elite, and others) boast a broad mix of top Nielsen-ranked channels across sports, news, and entertainment. The company operates in a single segment of the streaming business.